Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON23877Unknown
Double-blind trial of midomafetamine, ketanserin and pindolol (6 arms), sponsored by NWO. Primary endpoints: Neurocognitive measures of memory and Neurocognitive measures of impulse control. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON23877.